1. Home
  2. BLIN vs PHIO Comparison

BLIN vs PHIO Comparison

Compare BLIN & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgeline Digital Inc.

BLIN

Bridgeline Digital Inc.

HOLD

Current Price

$0.73

Market Cap

9.2M

Sector

Technology

ML Signal

HOLD

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$1.28

Market Cap

12.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLIN
PHIO
Founded
2000
2011
Country
United States
United States
Employees
40
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
12.3M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
BLIN
PHIO
Price
$0.73
$1.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$4.62
$10.67
AVG Volume (30 Days)
54.6K
8.4M
Earning Date
02-12-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,383,000.00
N/A
Revenue This Year
$22.67
N/A
Revenue Next Year
$21.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.16
N/A
52 Week Low
$0.69
$0.81
52 Week High
$2.22
$4.19

Technical Indicators

Market Signals
Indicator
BLIN
PHIO
Relative Strength Index (RSI) 37.20 65.39
Support Level $0.73 $0.81
Resistance Level $0.84 $1.48
Average True Range (ATR) 0.05 0.09
MACD -0.00 0.03
Stochastic Oscillator 27.16 71.53

Price Performance

Historical Comparison
BLIN
PHIO

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Share on Social Networks: